Navigation Links
Exposing the Double Standard of the Forgotten Cancer: Biggest Cancer Killer for Women and Men, Lung Cancer, Receives Least Research Funds
Date:12/21/2009

Lung Cancer Foundation of America (LCFA), http://lcfamerica.org, new organization trying to give the gift of life this holiday season by highlighting lack of research funding and providing critical support for lung cancer. Lung cancer remains biggest cancer killer for women and men yet receives least funds for research because lung cancer remains only cancer where victims are stigmatized and blamed for their disease.

Los Angeles, CA (PRWEB) December 21, 2009 -- Lung cancer, the nation’s leading cause of cancer deaths for women and men, remains the most under-funded, under-researched and under-supported cancer. There are currently no approved early detection tests for lung cancer. With a 5-year survival rate of only 15%, the prognosis for lung cancer has not changed in 40 years. A new organization, Lung Cancer Foundation of America (LCFA) is trying to change this reality, and save lives by dramatically increasing the five-year survival rate for all stages of lung cancer. LCFA will accomplish this by providing the necessary and critical funding for creative and leading edge lung cancer research programs.

Barely two years old, LCFA is proud to partner with the International Association for the Study of Lung Cancer (IASLC) in announcing its inaugural Request for Proposal for a research award in the amount of $125,000 this Holiday Season. LCFA and IASLC are partnering to fund exciting lung cancer research opportunities for molecular analysis of bio-specimens (blood, tissue, urine, etc.) collected as part of medium to large clinical trials.

“Lung cancer has been the forgotten cancer for far too long,” said Kim Norris, the President of LCFA. “Research grants like this are a critical first step towards giving hope to the patients, families and friends of those affected by this insidious disease. But much more needs to be done to save lives.”

Current public and private funding for lung cancer mostly focuses on prevention, which is only one part of the equation. Early detection and treatment are just as critical, especially because it is estimated that 60% of new lung cancer diagnoses will be in non-smokers - a combination of 45-50% former smokers (many who quit 10, 20, even 30 years prior to the onset of lung cancer) and people who have never smoked. These former smokers did the right thing … they quit. Little do they know that they are still at risk for lung cancer and just like lung cancer victims who have never smoked, they will be shocked to discover how few treatment options are available to them. In 2009 more than 214,000 people in this country will be diagnosed with lung cancer and more than 157,000 will die from it.

LCFA is one of only a handful of private foundations devoted to the research of early detection and treatment of lung cancer. As of 2006, there were less than 30 lung cancer specific foundations providing lung cancer research grants, all of which combined did not give more than $5 million dollars in grant money. At the same time, this year, lung cancer will claim more lives than breast, prostate, colon, liver, kidney and melanoma cancers – COMBINED, all of which underscores the importance of this grant and others like it.

About LCFA:
LCFA was established by two lung cancer survivors and a lung cancer widow. Although their life experiences vary greatly the three of them have come to the same realization…the poor survival rate for lung cancer is a direct result of the lack of funding for lung cancer research. Working with many of the top lung cancer researchers and clinicians in this country, LCFA has seen how lung cancer researchers are trying diligently to unlock the secrets unique to lung cancer. They have also witnessed the inordinate amount of time researchers spend in an effort to secure money to pay for the research, an effort that distracts them from their primary research function. The abysmal state of funding for lung cancer research also discourages new researchers who, instead, gravitate to where the money is, leaving a potential gaping hole in future lung cancer research programs. LCFA's mission is to save lives by dramatically increasing the five-year survival rates for all stages of lung cancer, the nation's leading cause of cancer deaths for both men and women. LCFA will accomplish this by providing the necessary and critical funding for creative and leading edge lung cancer research programs. http://lcfamerica.org/

For more information contact Rachel Schwartz at PR AdvantEDGE, Inc., http://pr-a.biz/.

###

Read the full story at http://www.prweb.com/releases/giftoflifeforlungcancer/lungcancerfoundation/prweb3370244.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tobacco-Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking
2. Northwestern exposing most deadly infectious diseases in 3-D
3. As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM
4. Human Testing - Exposing Children to Chemicals
5. Stopping Statins After Stroke Doubles Death Risk
6. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
7. Guardians Dental Network Experiences Double-Digit Growth
8. Researchers say lack of sleep doubles risk of death... but so can too much sleep
9. Making the Case: special double issue of Critical Inquiry
10. Double cardiovascular benefit for people with chronic kidney disease
11. Anti-depressant drugs can double risk of gastrointestinal bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)...   TriNetX , the health research network, ... signed a membership agreement to join the network ... cures. The TriNetX network is comprised ... globally, biopharmaceutical companies and contract research organizations (CROs) ... site selection, patient recruitment, and collaborative research across ...
(Date:12/8/2016)...  A new study by a pair of Geisinger ... therapy to treat chronic pain is not only ineffective, ... consequences, including death. Palliative care physicians ... , M.D., authored the study which provides a review ... study was published in the December 2016 edition of ...
Breaking Medicine Technology: